Avecho Biotechnology Ltd (AVE) TRADING HALT SUSPENDED

20mins delayed


1 Year Return

Avecho Biotechnology Ltd Chart

Share price
Market Cap $22.36 million
Today's Movement
Prev. Close
Day Range -
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover

AVE Statistics

23 October

1,572 / 2,222

ASX Size Rank

1yr Return

vs Sector (1yr)


vs ASX 200 (1yr)


$22.36 million

Market Cap

Share Issue

1.6 billion

All Ords (%)


Short Sold


Current Fundamentals

23 October


PE Ratio

EPS ($)


Earnings Yield


NTA ($)



Dividend Yield

DPS ($)


Gross Div. Yield


Gross DPS ($)


Company Overview

Avecho Biotechnology Limited (AVE , formerly Phosphagenics Limited) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix).

Former Names
Vital Capital Limited (VIT), 9/2/2004; Greenchip Development Capital Limited (GDC), 27/04/1999; Phosphagenics Limited (POH ), 24/05/2019

Avecho Biotechnology Ltd Logo

Corporate Details

Head Office: Clayton
Managing Director: Paul Gavin
GICS Sub-Industry: Pharmaceuticals
Date Listed: 11 Aug 1993
Registry: Computershare
Similar Companies: SPL / MYX / AFP / EOF / MVP

Upcoming Calendar

1 Mar 2021 Report (Prelim)
1 Mar 2021 Report (Annual)
27 Aug 2021 Report (Interim)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.


Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

AVE is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data

Name Title Since Bio
Dr Gregory (Greg) Collier Non-Executive Chairman, Non-Executive Director Apr 2019
Mr David Segal Non-Executive Director May 2016
Dr Ross Murdoch Non-Executive Director Apr 2015
Mr Matthew Patrick McNamara Non-Executive Director Jan 2020
Ms Melanie Jaye Leydin Chief Financial Officer, Company Secretary Dec 2018
Dr Paul Gavin Chief Executive Officer May 2020
Paul Gavin Chief Executive Officer N/A

Director Transactions

About the Data

AVE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code AVE in our database.

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 459 903 671 2,016 1,188 5,237

Top 20 Shareholders

About the Data

Name Shares Capital
Mr Mark Gregory Kerr (Lindmark Inv Staff S/F A/C) 93,071,745 5.90%
HSBC Custody Nominees (Australia) Limited 86,209,916 5.47%
Mr Mark Gregory Kerr & Mrs Linda Marie Kerr (Lindmark Inv Staff S/F A/C) 67,153,797 4.26%
BNP Paribas Noms Pty Ltd (DRP) 41,991,591 2.66%
Paradyce Pty Ltd (The Paradyce A/C) 38,600,000 2.45%
Rosscope Pty Ltd (Ross Copeland Family A/C) 30,558,184 1.94%
Mr Ross Copeland & Mrs Gina Copeland 23,018,212 1.46%
ACK Pty Ltd (Markoff Super No 2 A/C) 20,494,147 1.30%
Kazakco Pty Ltd (Kent Family A/C) 20,000,000 1.27%
Citicorp Nominees Pty Limited 19,944,950 1.26%
Churchcourt Pty Limited 19,162,500 1.21%
Mr Ross Graham Copeland & Mrs Gina Copeland (Publicity Press S/F A/C) 16,868,545 1.07%
Mr Brandon Armon Batagol 16,005,597 1.01%
Dr Maurice Arthur Trewhella & Mrs Elizabeth Trewhella (Simpetejen Super Fund A/C) 16,000,000 1.01%
Servbond Pty Limited (Servbond Pty Ltd S/F A/C) 16,000,000 1.01%
Citycastle Pty Ltd 15,600,000 0.99%
BHL Pension Pty Ltd (BHL Pension Fund A/C) 15,000,000 0.95%
Mr Gary Dean Shaw 15,000,000 0.95%
Mrs Susan Margaret Chudleigh & Mr John West Chudleigh 14,000,000 0.89%
J P Morgan Nominees Australia Pty Limited 13,166,434 0.83%
All other shareholders 62.11 %

The Top 20 Shareholders of AVE hold 37.89% of shares on issue.

AVE Share Price History

Date Close Change % Change Open High Low Volume Turnover

AVE Historical Data

Download up to 20 years of share price history.

Year Closing Price (30 June) Last Trade
2020 $0.007 30 June
2019 $0.003 28 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development, production, sale and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skin care and animal health and nutrition industries.

Incorporated: in VIC on 19/06/1992 as Greenchip Development Capital Ltd. Name changed to Vital Capital Limited on 27/04/1999. Name changed to Phosphagenics Limited on 10/2/2004. Changed GICS from 4020 Diversified Financials to 3520 Pharmaceuticals & Biotechnology on 4/3/2005.

Unit A8, Hallmarc Business Park, 2A Westall Rd
Clayton VIC 3168

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.